Alpha 2.0
Login Register
» Authors » Michael Peake

Michael Peake

Explore the profile of Michael Peake including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 963
Followers 0
Related Specialties
Oncology
Biochemistry
General Medicine
Top 10 Co-Authors
Ralf Paus
Georgios Lyratzopoulos
Andrew G Nicholson
Sean McPhail
Talveen S Purba
Mark Krasnik
Lars Brunken
Nikolaos T Georgopoulos
Renze Bais
Vanessa Bolejack
Published In
Lancet Oncol
Br J Cancer
Cancer Epidemiol
Clin Biochem Rev
J Thorac Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
A novel method for the establishment of autologous skin cell suspensions: characterisation of cellular sub-populations, epidermal stem cell content and wound response-enhancing biological properties
Peake M, Dunnill C, Ibraheem K, Smith A, Clarke D, Georgopoulos N
Front Bioeng Biotechnol . 2024 Apr; 12:1386896. PMID: 38646012
Autologous cell suspension (ACS)-based therapy represents a highly promising approach for burns and chronic wounds. However, existing technologies have not achieved the desired clinical success due to several limitations. To...
2.
Solar urticaria involves rapid mast cell STAT3 activation and neutrophil recruitment, with FcεRI as an upstream regulator
Rutter K, Peake M, Hawkshaw N, Scholey R, Bulfone-Paus S, Friedmann P, et al.
J Allergy Clin Immunol . 2024 Jan; 153(5):1369-1380.e15. PMID: 38184075
Background: Solar urticaria is a rare photodermatosis characterized by rapid-onset sunlight-induced urticaria, but its pathophysiology is not well understood. Objective: We sought to define cutaneous cellular and molecular events in...
3.
Promoting early diagnosis and recovering from the COVID-19 pandemic in lung cancer through public awareness campaigns: learning from patient and public insight work
Evison M, Taylor S, Grundy S, Perkins A, Peake M
BMJ Open Respir Res . 2021 Nov; 8(1). PMID: 34750168
COVID-19 has had a devastating impact on outcomes in lung cancer leading to later stage presentation, less curative treatment and higher mortality. This has amplified the existing problem of late-stage...
4.
Cooling-mediated protection from chemotherapy drug-induced cytotoxicity in human keratinocytes by inhibition of cellular drug uptake
Dunnill C, Ibraheem K, Peake M, Ioannou M, Palmer M, Smith A, et al.
PLoS One . 2020 Oct; 15(10):e0240454. PMID: 33057448
Chemotherapy-induced alopecia (CIA) represents the most distressing side-effect for cancer patients. Scalp cooling is currently the only treatment to combat CIA, yet little is known about its cytoprotective effects in...
5.
Impact on survival of modelling increased surgical resection rates in patients with non-small-cell lung cancer and cardiovascular comorbidities: a VICORI study
Welch C, Sweeting M, Lambert P, Rutherford M, Jack R, West D, et al.
Br J Cancer . 2020 May; 123(3):471-479. PMID: 32390010
Background: The impact of cardiovascular disease (CVD) comorbidity on resection rates and survival for patients with early-stage non-small-cell lung cancer (NSCLC) is unclear. We explored if CVD comorbidity explained surgical...
6.
Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group
Spiro S, Shah P, Rintoul R, George J, Janes S, Callister M, et al.
Eur Respir J . 2019 Sep; 54(4). PMID: 31537697
Background: Low-dose computed tomography (LDCT) screening detects early-stage lung cancer and reduces mortality. We proposed a sequential approach targeted to a high-risk group as a potentially efficient screening strategy. Methods:...
7.
Establishing population-based surveillance of diagnostic timeliness using linked cancer registry and administrative data for patients with colorectal and lung cancer
Pearson C, Fraser J, Peake M, Valori R, Poirier V, Coupland V, et al.
Cancer Epidemiol . 2019 Jun; 61:111-118. PMID: 31207483
Background: Diagnostic timeliness in cancer patients is important for clinical outcomes and patient satisfaction but, to-date, continuous monitoring of diagnostic intervals in nationwide incident cohorts has been impossible in England....
8.
Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions
Eden M, Harrison S, Griffin M, Lambe M, Pettersson D, Gavin A, et al.
Cancer Epidemiol . 2019 Jan; 58:184-192. PMID: 30639877
Background: International cancer survival comparisons use cancer registration data to report cancer survival, which informs the development of cancer policy and practice. Studies like the International Cancer Benchmarking Partnership (ICBP)...
9.
Sociodemographic variation in the use of chemotherapy and radiotherapy in patients with stage IV lung, oesophageal, stomach and pancreatic cancer: evidence from population-based data in England during 2013-2014
Henson K, Fry A, Lyratzopoulos G, Peake M, Roberts K, McPhail S
Br J Cancer . 2018 May; 118(10):1382-1390. PMID: 29743552
Background: Sociodemographic inequalities in cancer treatment have been generally described, but there is little evidence regarding patients with advanced cancer. Understanding variation in the management of these patients may provide...
10.
Divergent proliferation patterns of distinct human hair follicle epithelial progenitor niches in situ and their differential responsiveness to prostaglandin D2
Purba T, Peake M, Farjo B, Farjo N, Bhogal R, Jenkins G, et al.
Sci Rep . 2017 Nov; 7(1):15197. PMID: 29123134
Human scalp hair follicles (hHF) harbour several epithelial stem (eHFSC) and progenitor cell sub-populations organised into spatially distinct niches. However, the constitutive cell cycle activity of these niches remains to...